CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,034 Cr | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr | ₹1,313 Cr |
What is the latest Total Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,034 Cr |
| Mar2024 | ₹1,701 Cr |
| Mar2023 | ₹1,514 Cr |
| Mar2022 | ₹1,502 Cr |
| Mar2021 | ₹1,313 Cr |
How is Total Liabilities of CONCORD BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,034 Cr | 19.61 | |
| Mar2024 | ₹1,701 Cr | 12.33 | |
| Mar2023 | ₹1,514 Cr | 0.81 | |
| Mar2022 | ₹1,502 Cr | 14.41 | |
| Mar2021 | ₹1,313 Cr | - | |
Compare Total Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,301.5 Cr | -1.2% | 5% | -30.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.2% |
5% |
-30.6% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses